(Total Views: 83)
Posted On: 02/08/2021 3:55:49 PM
Post# of 35714
$SRNE News Article - Sorrento Announces Subsidiary Company - ADNAB, Inc. - to Develop and Commercialize ADNAB(TM) Platform Products for Hematological Malignancies and Solid Tumors Based on an Exclusive Technology License From the Mayo Clinic https://marketwirenews.com/news-releases/sorr...78532.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
